Halozyme Reports Third Quarter 2019 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Halozyme Reports Third Quarter 2019 Results

Halozyme Therapeutics (HALO) Misses Q3 EPS by 5c

November 12, 2019 4:32 PM EST

Halozyme Therapeutics (NASDAQ: HALO) reported Q3 EPS of ($0.17), $0.05 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $46.2 million versus the consensus estimate of $54.93 million.

GUIDANCE:

Halozyme Therapeutics sees FY2019 revenue of $195-205 million, versus the consensus of $204.9... More